Sökning: id:"swepub:oai:lup.lub.lu.se:27dbf388-213f-47ad-a13e-ccce5923379d" > Use of terbinafine ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03935naa a2200397 4500 | |
001 | oai:lup.lub.lu.se:27dbf388-213f-47ad-a13e-ccce5923379d | |
003 | SwePub | |
008 | 181123s2019 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/27dbf388-213f-47ad-a13e-ccce5923379d2 URI |
024 | 7 | a https://doi.org/10.1002/ijc.319012 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Ji, Jianguangu Lund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups,Region Skåne4 aut0 (Swepub:lu)med-jji |
245 | 1 0 | a Use of terbinafine and risk of death in patients with prostate cancer : A population-based cohort study |
264 | c 2018-11-04 | |
264 | 1 | b Wiley,c 2019 |
520 | a Terbinafine is used for the treatment of several superficial fungal infections. In silico analyses and animal models suggest that terbinafine might have an anti-tumor effect. We aimed to explore whether subsequent administration of terbinafine might be associated with a lower mortality rate in patients with prostate cancer. We identified patients diagnosed with prostate cancer between July 2005 and December 2014 from the Swedish Cancer Registry, and linked them to the Swedish Prescribed Drug Register to ascertain subsequent use of terbinafine. A total of 799 patients received oral treatment of terbinafine during the study period with a mortality rate of 18.6 per 1,000 person-years. Compared to patients who did not use terbinafine and adjusting for a range of confounding factors, patients that received oral treatment of terbinafine had a decreased risk of death from prostate cancer (HR, 0.53; 95% CI, 0.38–0.73) and a decreased risk of death overall (HR, 0.64; 95% CI, 0.52–0.77). To account for indication bias, we further identified 907 patients who received topical use of terbinafine. However, the risk of death from prostate cancer in patients with topical use of terbinafine was 0.92 (95% CI 0.74–1.12) and the risk of death overall was 1.03 (95% CI 0.91–1.17) as compared to the controls, which suggests that there was no association between risk of death in patients with prostate cancer with topical use of terbinafine. These findings suggest that this drug's potential anti-tumor effect needs to be explored further. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a cohort study | |
653 | a cox-regression | |
653 | a epidemiology | |
653 | a mortality | |
653 | a prostate cancer | |
653 | a register-based study | |
653 | a terbinafine | |
700 | 1 | a Sundquist, Janu Lund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups,Icahn School of Medicine at Mount Sinai,Region Skåne4 aut0 (Swepub:lu)med-jsu |
700 | 1 | a Sundquist, Kristinau Lund University,Lunds universitet,Allmänmedicin, kardiovaskulär epidemiologi och levnadsvanor,Forskargrupper vid Lunds universitet,Family Medicine, Cardiovascular Epidemiology and Lifestyle,Lund University Research Groups,Icahn School of Medicine at Mount Sinai,Region Skåne4 aut0 (Swepub:lu)med-ksq |
710 | 2 | a Allmänmedicin och klinisk epidemiologib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t International Journal of Cancerd : Wileyg 144:8, s. 1888-1895q 144:8<1888-1895x 0020-7136x 1097-0215 |
856 | 4 | u http://dx.doi.org/10.1002/ijc.31901y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/27dbf388-213f-47ad-a13e-ccce5923379d |
856 | 4 8 | u https://doi.org/10.1002/ijc.31901 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy